mrtx1133,cetuximab,asp3082,rmc-6236
eli lilly,mirati,revolution medicines,astellas
[]
targeting kras is now possible- some stable disease/partial responses to g12c inhibs in #pdac. will we build on that w g12d inhibs and pan-kras inhibitors? what new combos will this unlock? keep these trials handy for pts! #asco23 great talk by 
Oncology Fellow. Scientist. Entrepreneur. Turning basic science into medicine. Crowdsourcing precision oncology wisdom with @TumorBoardTues